Did Earl Blumenauer buy Quest Diagnostics stock?

Common questions

Did Earl Blumenauer buy Quest Diagnostics stock?

Yes. Earl Blumenauer disclosed 1 purchase and 1 sale of Quest Diagnostics (DGX) stock between Mar 2, 2020 and Apr 4, 2024, in STOCK Act reports. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $1K-$15K.

How big were Earl Blumenauer's Quest Diagnostics trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $1K-$15K.

Did Earl Blumenauer make these Quest Diagnostics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Earl Blumenauer still own Quest Diagnostics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Earl Blumenauer report these trades?

The latest filing is dated May 4, 2024. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.